Microfluidics in the open space for performing local chemistries on biological interfaces.
Kaigala, G. V., Lovchik, R. D. and Delamarche, E.
Angew. Chem. 2012, 51, 11224-11240.

Micro-immunohistochemistry using a microfluidic probe.
Lovchik, R. D., Kaigala, G. V., Georgiadis, M. and Delamarche, E.
Lab Chip 2012, 12, 1040-1043.

Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
Soltermann A, Tischler V, Arbogast S, Braun J, Probst-Hensch N, Weder W, Moch H, Kristiansen G.
Clin Cancer Res. 2008;14:7430-7.

Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma.
Schramm A, Opitz I, Thies S, Seifert B, Moch H, Weder W, Soltermann A.
Eur J Cardiothorac Surg. 2010;37:566-72.

L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.
Tischler V, Pfeifer M, Hausladen S, Schirmer U, Bonde AK, Kristiansen G, Sos ML, Weder W, Moch H, Altevogt P, Soltermann A.
Mol Cancer. 2011;10:127.

Relevance of Periostin Splice Variants in Renal Cell Carcinoma.
Morra L, Rechsteiner M, Casagrande S, van Duc L, Santimaria R, Diener PA, Sulser T, Kristiansen G, Schraml P, Holger M, Soltermann A.
Am J Pathol. 2011;179:1513-21.

Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
Bonde AK, Tischler V, Kumar S, Soltermann A, Schwendener RA.
BMC Cancer 2012; 24;12:35.

Characterization of periostin isoform pattern in non-small cell lung cancer.
Morra L, Rechsteiner M, Casagrande S, von Teichman A, Schraml S, Moch H, Soltermann A.
Lung Cancer 2012;76:183-90.

Epithelial-mesenchymal transition in non-small cell lung carcinoma.
Soltermann A.
Der Pathologe. 2012;33 Suppl 2:311-7.